The oncologist Journal

Overview
Identity
View All

publication venue for

Oncology drug pricing: potential Medicare savings on cancer-directed and supportive care medications through the Mark Cuban cost plus drug model.. 29:e918-e921. 2024
Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer. 2024
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.. 29:e351-e359. 2024
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.. 28:e1219-e1229. 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.. 28:e625-e632. 2023
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.. 28:e488-e492. 2023
Specialty Differences in Medical Aid in Dying Experiences: Results of a Survey of Physicians in Colorado.. 28:e585-e587. 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. 2023
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.. 28:494-500. 2023
A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?. 28:105-115. 2023
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology.. 27:778-789. 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life.. 27:694-702. 2022
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).. 27:e494-e505. 2022
Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers.. 27:e37-e44. 2022
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced Cancer.. 26:e2181-e2191. 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist.. 26:e1992-e2001. 2021
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017.. 26:e1890-e1892. 2021
Patient-Reported Continuity of Care and Functional Safety Concerns After Inpatient Cancer Rehabilitation.. 26:887-896. 2021
Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life.. 26:310-317. 2021
Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.. 26:208-214. 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.. 26:99-e217. 2020
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).. 26:e435-e444. 2020
Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study.. 25:591-597. 2020
Opioid Prescribing Trends in Women Following Mastectomy or Breast-Conserving Surgery Before and After the 2014 Federal Reclassification of Hydrocodone.. 25:281-289. 2019
Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.. 25:e94-e108. 2019
Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans.. 24:1166-1173. 2019
Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.. 24:e828-e834. 2019
Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.. 24:e292-e302. 2019
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).. 24:e284-e291. 2019
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice.. 24:e397-e399. 2019
Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.. 24:e828-e834. 2019
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.. 24:617-623. 2018
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.. 23:1388-1390. 2018
At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.. 23:1242-1249. 2018
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).. 23:1016-1023. 2018
Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.. 23:468-473. 2017
Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.. 21:165-71. 2015
Toxicity of bevacizumab in combination with chemotherapy in older patients.. 18:408-14. 2013
Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study.. 15:636-47. 2010
Polypharmacy in older adults with cancer.. 15:507-22. 2010
Never too old? Age should not be a barrier to enrollment in cancer clinical trials.. 10:198-204. 2005
The Matilda Effect: Under‐recognition of Women in Hematology and Oncology Awards 2021